High Intensity Interval Training Versus Moderate Intensity Continuous Training in Frail Elderly
ConditionFrail Elderly
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age70+
SponsorUniversity Hospital, Grenoble
About this trial
The assessment and systematic integration of physical activity into the care pathway of frail elderly people is essential to prevent loss of independence and improve the quality of life of this population. This project, which is part of routine care, aims to evaluate the practices and, in particular, the effects of different types of physical exercise currently in use at the Health and Sport Center of the Grenoble Alpes University Hospital. It therefore aims to optimize professional practices without changing the standard care provided to patients. Recommendations regarding intensity during cardiorespiratory endurance training sessions (moderate to high, taking into account emotional factors) are broad and vary greatly in their application depending on the facilities that work with older adults. This project aims to compare the exercise methods used on ergocycle at Health and Sport Center of Grenoble Alpes University Hospital: high-intensity interval training (HIIT) vs. moderate-intensity continuous training (MICT) to reverse the functional decline that occurs in frail older adults.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults aged 70 or older;
Patients meeting at least 1 of 5 frailty criteria (Fried criteria; 2001);
Patient does not object to the analysis of anonymized data;
Person affiliated with social security;
Disqualifiers
Unstable medical conditions that may be aggravated by physical activity (as determined by a physician)
Musculoskeletal disorders and severe neurocognitive conditions that make it impossible to safely use the ergocycle or participate in the exercise program
individuals participating in other interventional studies or who have recently participated in an interventional study that could influence the results of this study
Persons referred to in Articles L1121-5 to L1121-8 of the public health code (corresponds to all protected persons: pregnant women, women in labor, breastfeeding mothers, persons deprived of their liberty by judicial or administrative decision, persons subject to legal protection measures)
Trial population
Patients aged \>70 years are receiving routine care. They are identified as frail (3 positive criteria out of 5 according to Fried) or pre-frail (1 to 2 positive criteria out of 5 according to Fried) in the Geriatric Department of Grenoble Alpes Universitary Hospital (CHUGA) (Prof. Gavazzi) and are referred to the EXPLORASUD Sport and Health Center at CHU Sud (Dr. Coudurier, Dr. Doutreleau) for support through physical activity.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Exercise Training
Procedure/SurgeryAdapted High Intensity Interval Training (HIIT), Moderate-Intensity Continuous training (MICT), therapeutic education workshops to help people become independent regarding their program
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Cardiorespiratory endurance (VO2peak)
in mL/kg/min with an ergospirometer during a maximal progressive test
Time frame
At weeks 0, 8 and 24Secondary outcomes
1
Fried's frailty criteria
muscle weakness (grip strength in the lowest 20th percentile), reduced gait speed (\< 0.8 m/s), self-reported fatigue, low physical activity levels (\< 383 kcal/day for men and \< 270 kcal/day for women), unintentional weight loss (\> 5% body weight over 12 months)
Time frame
At weeks 0, 8 and 242
Weight
Weight scale in kg
Time frame
At Weeks 0, 8 and 243
Height
in cm with a measuring rod
Time frame
At weeks 0, 8 and 244
Body composition
fat mass, fat-free mass, in kg and as percentages of total body weight with bioelectrical impedance analysis using a standardized body composition analyzer (Tanita BC 418 MA; Tanita Corp., Tokyo, Japan)
Time frame
At weeks 0, 8 and 24Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov